Recent Articles from GlobeNewswire

The partnership combines ACS’s Bullfrog autonomous weapon station with CX2’s RF sensing and electronic warfare technology to advance layered counter-UAS defense solutions

Following a challenge brought by GuruNanda, LLC, BBB National Programs’ National Advertising Division reviewed advertising claims made by Davids Health Sciences, Inc. for its Pulling Oil Oral Rinse, including claims regarding certain of the product’s oral health benefits and a claim that the product is “Proudly made in USA.”

Following a challenge by The Procter & Gamble Company (P&G), BBB National Programs’ National Advertising Division determined that Clutch, Inc. d/b/a Carpe provided a reasonable basis for the $19.95 reference price used in its Underarm Stick savings claims, but recommended that Carpe modify or discontinue other challenged advertising, including savings, free shipping, comparative performance, and “first” 100-hour sweat and odor control claims.

NEWPORT NEWS, Va., Oct. 30, 2026 (GLOBE NEWSWIRE) -- HII (NYSE: HII) announced today the appointment of Renee Swan to executive vice president and chief human resources officer (CHRO), effective Dec. 7, 2026. Swan comes to HII from Nashville-based Atmus Filtration Technologies (NYSE: ATMU), where she served as senior vice president and chief people officer.

LOS ANGELES, Oct. 30, 2026 (GLOBE NEWSWIRE) -- Schall, Brown & Schwartz LLP (“SBS”), a national shareholder rights litigation firm, reminds investors of a class action lawsuit against D-Wave Quantum Inc. (“D-Wave” or “the Company”) (NASDAQ: QBTS) for violations of §§10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder by the U.S. Securities and Exchange Commission.

LOS ANGELES, Oct. 30, 2026 (GLOBE NEWSWIRE) -- Schall, Brown & Schwartz LLP (“SBS”), a national shareholder rights litigation firm, reminds investors of a class action lawsuit against Millrose Properties, Inc. (“Millrose” or “the Company”) (NYSE: MRP) for violations of §§10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder by the U.S. Securities and Exchange Commission.

LOS ANGELES, Oct. 30, 2026 (GLOBE NEWSWIRE) -- Schall, Brown & Schwartz LLP (“SBS”), a national shareholder rights litigation firm, reminds investors of a class action lawsuit against Bank of America Corporation (“Bank of America” or “the Company”) (NYSE: BAC) for violations of §§10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder by the U.S. Securities and Exchange Commission.

LOS ANGELES, Oct. 30, 2026 (GLOBE NEWSWIRE) -- Schall, Brown & Schwartz LLP (“SBS”), a national shareholder rights litigation firm, reminds investors of a class action lawsuit against Gildan Activewear Inc. (“Gildan” or “the Company”) (NYSE: GIL) for violations of §§10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder by the U.S. Securities and Exchange Commission.

Ingelheim, Germany and Ridgefield, Conn., U.S. - Boehringer Ingelheim today announced the registration of the Phase III AIRWARD™ trial evaluating its investigational oral therapy verducatib as a treatment option targeting DPP1 in adults with COPD; the trial was published on ClinicalTrials.gov (NCTXXXXXX).1 The trial will evaluate verducatib, an investigational dipeptidyl peptidase 1 (DPP1) inhibitor, in adults who continue to experience exacerbations, despite treatment with their usual therapy, and have a blood eosinophil count below 300 cells/µL.1 Building on more than 100 years of heritage in respiratory medicine and extensive experience in COPD, Boehringer is committed to addressing the needs of people who continue to experience exacerbations while receiving standard of care.

BALA CYNWYD, Pa., Oct. 30, 2026 (GLOBE NEWSWIRE) -- Brodsky & Smith reminds investors of the following investigations. If you own shares and wish to discuss the investigation, contact Jason Brodsky (jbrodsky@brodskysmith.com) or Marc Ackerman (mackerman@brodskysmith.com) at 855-576-4847. There is no cost or financial obligation to you.

The 16th China Photography Festival

SOUTH SAN FRANCISCO, Calif., Oct. 30, 2026 (GLOBE NEWSWIRE) -- Denali Therapeutics Inc. (Nasdaq: DNLI) today announced that AVLAYAH® (tividenofusp alfa-eknm) has been recognized as the “Best Biotechnology Product” of 2026 by The Galien Foundation. AVLAYAH is the first biologic approved by the U.S. Food and Drug Administration (FDA) that is specifically designed to cross the blood-brain barrier and reach the whole body, including the brain. AVLAYAH is an enzyme replacement therapy that received FDA accelerated approval in March 2026 for the treatment of neurologic manifestations of a rare neurodegenerative disease called Hunter syndrome (mucopolysaccharidosis type II, or MPS II) when initiated in presymptomatic or symptomatic pediatric patients weighing at least 5 kg prior to advanced neurologic impairment. Continued approval for this indication may be contingent upon verification of clinical benefit in a confirmatory study.

Strategic Combination Brings Highly Innovative Late-Stage D-Fi Franchise Targeting Rare Diseases, with Orphan Drug-Designated Lead Indication in Dystrophic Epidermolysis Bullosa (DEB)

The Second Intangible Cultural Heritage and Healthy Living Conference

ATLANTA, GA, Oct. 30, 2026 (GLOBE NEWSWIRE) -- Trust Stamp (NASDAQ:IDAI), a global provider of AI-powered software solutions, today announced the signing of a Master Technology Subcontract Agreement with E&P Limited, the Ghanaian company leading the deployment of AFCAS, a public-private partnership with the Ghana National Fire Service to digitise fire compliance and safety certification nationwide. Under the agreement, Trust Stamp is appointed the sole and exclusive technology subcontractor for the AFCAS programme.

ROCKVILLE, Md., Oct. 30, 2026 (GLOBE NEWSWIRE) -- X-Energy, Inc. (Nasdaq: XE) (“X-energy” or “the Company”), a leading developer of advanced nuclear reactors and fuel technology, today announced the completion of the U.S. Nuclear Regulatory Commission’s (“NRC”) safety review for the initial deployment of X-energy’s Xe-100 high-temperature gas-cooled reactor (“HTGR”). The proposed Long Mott Generating Station would be the first grid-scale advanced nuclear reactor at an industrial facility in U.S. history, advancing in partnership with Dow (NYSE: DOW) under the U.S. Department of Energy’s Advanced Reactor Demonstration Program (“ARDP”).

- Revuforj is the first and only menin inhibitor that is approved for adults and children one year and older with R/R NPM1m AML and KMT2A translocated acute leukemia -

LOS ANGELES, Oct. 30, 2026 (GLOBE NEWSWIRE) -- EVgo Inc. (Nasdaq: EVGO), one of the nation’s largest providers of public fast charging infrastructure for electric vehicles (EVs), today announced that it will release its third quarter financial results on Monday, November 9. This release will be followed by a webcast hosted by members of the EVgo management team at 9 a.m. ET (6 a.m. PT).

Starting at $29,000, the integrated system combines Supermicro hardware with VPP-accelerated VyOS LTS for IXPs, regional ISPs, and network operators that need 100 GbE routing without the integration burden

DURHAM, N.C., Oct. 30, 2026 (GLOBE NEWSWIRE) -- Atsena Therapeutics, a clinical-stage gene therapy company focused on reversing or preventing blindness from inherited retinal disease, today announced new preclinical data for ATSN-301, a gene therapy for the treatment of Usher Syndrome Type 1B (USH1B). ATSN-301 combines Atsena’s proprietary dual AAV vector (DNA recombination) technology with its laterally spreading AAV.SPR capsid to reconstitute full-length MYO7A and deliver it to the macula without the need for foveal detachment. The data demonstrated robust, full-length MYO7A expression, a favorable safety margin and no observed adverse effect level (NOAEL) at the highest dose tested in a six-month GLP toxicology study. These results are detailed in a manuscript posted to bioRxiv and in a presentation at the European Society for Gene and Cell Therapy (ESGCT) 33rd Annual Congress, taking place October 27-30, 2026, in Hamburg, Germany.

Redesigned site brings together information on BGLC’s operating businesses, healthcare initiatives and public disclosures

ATLANTA, Oct. 30, 2026 (GLOBE NEWSWIRE) -- Femasys Inc. (NASDAQ: FEMY), a leading biomedical innovator developing transformative fertility and non-surgical permanent birth control solutions designed to improve the standard of care, expand access, and reduce costs for women worldwide, announced today the appointment of John Moorhead to its Board of Directors as a board designee in connection with the Company’s August 2026 private placement. Mr. Moorhead brings more than two decades of experience in consumer marketing, brand development, product innovation and finance. He spent 12 years at Unilever’s Seventh Generation, where he rose to Chief Marketing Officer and helped transform the brand into a household name while more than quadrupling its Home Care business. Most recently, he served as Head of Marketing, North America, at SBM Life Science.

Research, naming, messaging, visual identity and website development help the national nonprofit express a mission of moving communities forward stronger

New integration gives Bright MLS subscribers access to RentRedi tenant prequalification, custom state-specific screening, and property management, right from within the listing, with the same system carrying forward after the lease is signed

PRESS RELEASE, October 30, 2026 – 08:00 CDT

With more than 25 years of leadership across aerospace, automotive battery systems and semiconductors, Ombach, ProLogium’s new independent director, will bring diverse market perspectives and insights into global industrial strategy and manufacturing at scale to enrich the Board’s strategic deliberations and help guide the company’s next phase of growth.

Hong Kong, Oct. 30, 2026 (GLOBE NEWSWIRE) -- Luda Technology Group Limited (NYSE American: LUD) (the “Company” or “Luda Technology”), a manufacturer and trader of stainless steel and carbon steel flanges and fittings products, and a trader of coal, today announced that on October [29], 2026, it had executed a share purchase agreement (the “Agreement”) with Asia AI Data Centre & Quantum Technology Company Limited ("AI Data Quant Tech") to acquire a 55% stake in AI Data Quant Tech, following the previously announced memorandum of understanding entered into by the parties in relation to the transaction.  The Agreement officially marks the Company’s entry into computing infrastructure operations management.

MOUNTAIN VIEW, Calif., Oct. 30, 2026 (GLOBE NEWSWIRE) -- Kodiak AI, Inc. (“Kodiak”) (Nasdaq: KDK), a leading provider of Physical AI-powered autonomous driving technology, today announced that its Autonomy Readiness Measure ("ARM") for long-haul driverless operations has increased to 99%, putting Kodiak ahead of pace to launch driverless long-haul commercial service by the end of 2026.

PHILADELPHIA, Oct. 30, 2026 (GLOBE NEWSWIRE) --

HAMILTON, Bermuda, Oct. 30, 2026 (GLOBE NEWSWIRE) -- Enstar Group Limited (“Enstar”) today announces the promotion of David Ni to President and the appointment of two senior industry executives to support its expansion and diversification across retrospective and specialist underwriting solutions.

Publicity Department of the CPC Sanya Municipal Committee

NAPLES, Fla. and CAMBRIDGE, United Kingdom, Oct. 30, 2026 (GLOBE NEWSWIRE) -- CDT Equity Inc. (Nasdaq: CDT) ("CDT" or the "Company"), today welcomed a significant development in the U.S. regulatory landscape for compounded peptides, which the Company believes is supportive of its strategic investment in Pep’d Inc., a U.S.-based peptide and telehealth company.

PHOENIX, Oct. 30, 2026 (GLOBE NEWSWIRE) -- Global Water Resources, Inc. (NASDAQ: GWRS), a pure-play water resource management company, has declared under its dividend policy a monthly cash dividend in the amount of $0.02533 per common share (an annual dividend rate of $0.30396 per share).

BROOMFIELD, Colo., Oct. 30, 2026 (GLOBE NEWSWIRE) -- Gogo (NASDAQ: GOGO) today announced that it has appointed Amy Greene as Vice President of Investor Relations, Communications and Government Affairs.

HOUSTON, Oct. 30, 2026 (GLOBE NEWSWIRE) -- Zone Frontier Inc. (NYSE American: ZONE) (the "Company" or “Zone Frontier”) today provided a shareholder update on its Minnesota data center campus, its project-level debt financing process, the completion of its exit from the legacy CleanCore cleaning products business, insider share purchases and its Potter County, Texas data center campus. The update coincides with the effectiveness of the Company’s 1-for-60 reverse stock split and the resumption of trading of its common stock on a split-adjusted basis on the NYSE American today.

Combining entertainment collectibles with preservation and authentication technology, Alliance Authentic continues to connect with collectors through exclusive releases and fan experiences

HOUSTON, Oct. 30, 2026 (GLOBE NEWSWIRE) -- Weatherford International plc (NASDAQ: WFRD) (“Weatherford” or the “Company”) today announced the redemption of all $236 million aggregate principal amount outstanding of its 8.625% Senior Notes due 2030 (the “2030 Notes”). The notes are being redeemed at 100% of their principal amount, plus accrued and unpaid interest, using cash on hand.

MELBOURNE, Australia, Oct. 30, 2026 (GLOBE NEWSWIRE) -- Propanc Biopharma, Inc. (Nasdaq: PPCB) (“Propanc” or the “Company”), a biopharmaceutical company focused on developing novel treatments for chronic diseases including recurrent and metastatic cancer, today announced that key analytical development activities are underway, including immunogenicity assay feasibility, pharmacokinetic method optimization and stability testing, supporting preparations for the planned Phase 1b, First-In-Human study of the Company’s lead clinical candidate, PPC-001, in up to 50 advanced cancer patients with solid tumors.

Announces Regular Quarterly Cash Dividend of $0.20 Per Share

WALTHAM, Mass., Oct. 30, 2026 (GLOBE NEWSWIRE) -- Werewolf Therapeutics, Inc. (the “Company” or “Werewolf”) (Nasdaq: HOWL), an innovative biopharmaceutical company pioneering the development of conditionally activated therapeutics engineered to stimulate the body’s immune system for the treatment of cancer, today announced that it has been selected for an oral presentation and will present two posters at the upcoming Society for Immunotherapy of Cancer’s (SITC) 2026 Annual Meeting, taking place November 4-8, 2026, in Phoenix, Arizona.

SINGAPORE and HONG KONG, Oct. 30, 2026 (GLOBE NEWSWIRE) -- NETCLASS TECHNOLOGY INC (Nasdaq: NTCL; the “Company” or “NetClass”), a B2B smart education IT solutions provider with offices in Shanghai, Hong Kong, Singapore and Tokyo, today announced that its case study on multi-agent foreign language education received the Outstanding Case Award at the 2026 Digital Lifelong Learning International Conference.

AUSTIN, Texas, Oct. 30, 2026 (GLOBE NEWSWIRE) -- via IBN – NetworkNewsAudio announces the Audio Press Release (APR) titled “Inspection, Automation Equipment Could Be Overlooked Winners of the AI Buildout,” featuring Nightfood Holdings Inc. (OTCQB: NGTFD).

BUFORD, Ga., Oct. 30, 2026 (GLOBE NEWSWIRE) -- Polk County Mosquito Control has reduced populations of Aedes aegypti (its top problem species and a primary carrier of dengue, Zika, and chikungunya) by up to 95% after implementing Rad Source's Sterile Insect Technique (SIT) program with Sterile Insect Farms in Polk County, Florida.

NEW ALBANY, Ohio, Oct. 30, 2026 (GLOBE NEWSWIRE) -- Abercrombie & Fitch Co. (NYSE: ANF) will host its quarterly earnings conference call for all interested parties on Tuesday, November 24, 2026, at 8:30 a.m. ET. A press release detailing the company’s third quarter results is expected to be issued shortly after 7:30 a.m. ET.   In addition, a presentation of the third quarter results will be available on the company’s website at approximately 7:30 a.m. ET.

The OVIN Report identifies commercial-to-defense adaptation, autonomous systems, testing and trusted supply chains as priorities that management considers relevant to the Company's existing operations

Parties agree in principle to pursue acquisition of 100% of Tranglo, subject to definitive documentation and agreement with Ripple Markets APAC

Move supports the company’s long-term growth strategy and goal of pursuing a listing on the Nasdaq Stock Exchange

Completed enrollment in Phase 3 UPSTREAM MG trial of telitacicept in generalized myasthenia gravis; topline results remain on track for 1H27

HOUSTON, Oct. 30, 2026 (GLOBE NEWSWIRE) -- Fervo Energy (“Fervo” or the “Company”) (NASDAQ: FRVO), a global pioneer of next-generation geothermal energy, today announced that it will release third quarter 2026 financial and operational results before the market opens on Monday, November 9, 2026. The Company will host a webcast and conference call that same day at 10:00 a.m. ET (9:00 a.m. CT) to discuss the results.

New distribution agreement positions TULSA-PRO within the iMRI Suite offering through Cook Medical’s Copernicus™ program, expanding Profound’s commercial reach

NEW YORK, Oct. 30, 2026 (GLOBE NEWSWIRE) --

- Agreement complements revenue from standard gene expression and DRP® services

Transaction in Own Shares

MONTREAL, Oct. 30, 2026 (GLOBE NEWSWIRE) -- CN (TSX: CNR) (NYSE: CNI) announced today that its Board of Directors has approved a fourth-quarter 2026 dividend on the Company’s common shares outstanding. A quarterly dividend of ninety-one and a half cents (C$0.9150) per common share will be paid on December 30, 2026, to shareholders of record at the close of business on December 9, 2026.

MONTREAL, Oct. 30, 2026 (GLOBE NEWSWIRE) -- CN (TSX: CNR) (NYSE: CNI) today reported its financial and operating results for the third quarter ended September 30, 2026.

SAN FRANCISCO, Oct. 30, 2026 (GLOBE NEWSWIRE) -- Braveheart Bio, Inc. (Nasdaq: BRVE), a clinical-stage biopharmaceutical company developing next-generation therapeutics for hypertrophic cardiomyopathy (HCM) and other serious cardiovascular diseases, today announced that it will host an investor and analyst webinar on Friday, November 6, 2026, from 4:35 p.m. to 6:05 p.m. ET. The event will feature remarks on Braveheart Bio's cardiac myosin inhibitor program and the global clinical development of BHB-1893 in patients with obstructive HCM and non-obstructive HCM from Management and the following speakers:

SAN FRANCISCO, Oct. 30, 2026 (GLOBE NEWSWIRE) -- Braveheart Bio, Inc. (Nasdaq: BRVE), a clinical-stage biopharmaceutical company developing next-generation therapeutics for hypertrophic cardiomyopathy (HCM) and other serious cardiovascular diseases, today announced two upcoming presentations, including a late-breaking presentation of 52-week extension data for BHB-1893 in obstructive HCM, at the American Heart Association (AHA) Scientific Sessions 2026, taking place November 6-9, 2026, in Chicago, IL. Following the presentations, copies of the presentation materials will be available in the Investors section of the Braveheart Bio website.

TORONTO, Oct. 30, 2026 (GLOBE NEWSWIRE) -- Celestica Inc. (NYSE: CLS) (TSX: CLS), a global leader in data center infrastructure and advanced technology solutions, today announced that the Toronto Stock Exchange (the “TSX”) has accepted the Company's notice to launch a Normal Course Issuer Bid (the “Bid”).

Shanghai Coordination Center of World Cities Day

Organising Committee of Global Observance of World Cities Day

Highlights

Business combination expected to close on November 4, 2026, subject to Churchill XI shareholder approval; the combined company expected to begin trading on Nasdaq under ticker symbol “AGLT” on November 5, 2026.

SINGAPORE, Oct. 30, 2026 (GLOBE NEWSWIRE) -- Aurora Mobile Limited (NASDAQ: JG) ("Aurora Mobile" or the "Company"), a leading provider of customer engagement and marketing technology services, announced that Modellix.ai, its one unified platform for all AI media generation, is now available for ComfyUI. The integration gives creators and developers another way to use image, video, and audio models available through Modellix.ai, directly within visual, node-based workflows.

SANTIAGO, Chile, Oct. 30, 2026 (GLOBE NEWSWIRE) -- Banco Santander Chile (NYSE: BSAC; SSE: Bsantander) announced today its results1 for the nine-month period ended September 30, 2026, and third quarter 2026 (3Q26).

-- Topline data show that ALTITUDE-AD did not meet the primary endpoint of change from baseline in cognitive and functional decline as measured by the Integrated Alzheimer’s Disease Rating Scale (iADRS) at 18 months compared to placebo at either dose; key secondary endpoints, including CDR-SB, also did not achieve statistical significance --

BURLINGTON, Mass., Oct. 30, 2026 (GLOBE NEWSWIRE) -- Fractyl Health, Inc. (Nasdaq: GUTS) (the Company or Fractyl), a clinical-stage metabolic therapeutics company focused on pioneering novel approaches to treat obesity and type 2 diabetes (T2D), today announced additions to its U.S. patent portfolio that strengthen the intellectual property foundation for investigational Revita® as the Company advances toward a planned U.S. Food and Drug Administration (FDA) De Novo marketing submission for post-GLP-1 weight maintenance.

Mount Laurel, NJ., Oct. 30, 2026 (GLOBE NEWSWIRE) --  J & J Snack Foods Corp. (Nasdaq: JJSF) today announced that it will release financial results for its fourth quarter and fiscal year ended September 26, 2026, before the stock market opens on Wednesday, November 18, 2026. The Company will hold a conference call and webcast to discuss the results at 10:00 a.m. Eastern Time that same day.

WILMINGTON, Del., Oct. 30, 2026 (GLOBE NEWSWIRE) -- NRx Pharmaceuticals, Inc. (Nasdaq: NRXP, “NRx” or “the Company”), a commercial biopharmaceutical company developing medicines that target depression, PTSD, and suicidality today announced that the U.S. Food and Drug Administration (FDA) has approved the Company’s Abbreviated New Drug Application (ANDA) for Preservative-Free Ketamine. The approval comes ahead of the FDA-announced November 10, approval goal date.

NEW YORK, Oct. 30, 2026 (GLOBE NEWSWIRE) -- OTC Markets Group Inc. (OTCQX: OTCM), operator of regulated markets for trading 12,000 U.S. and international securities, today announced Pacifica Silver Corp. (CSE: PSIL; OTCQX: PAGFF), a mineral exploration company, has qualified to trade on the OTCQX® Best Market. Pacifica Silver Corp. upgraded to OTCQX from the OTCQB® Venture Market.

NEW YORK, Oct. 30, 2026 (GLOBE NEWSWIRE) -- Syndax Pharmaceuticals (Nasdaq: SNDX), a commercial-stage biopharmaceutical company advancing innovative cancer therapies, today announced that Michael A. Metzger, Chief Executive Officer, as well as members of the Syndax management team, will participate in the following upcoming investor conferences:

INDIANAPOLIS, Oct. 30, 2026 (GLOBE NEWSWIRE) -- Kite Realty Group (NYSE: KRG), a premier owner and operator of high-quality, open-air grocery-anchored shopping centers and vibrant mixed-use assets, reported today its operating results for the third quarter ended September 30, 2026. For the quarters ended September 30, 2026 and 2025, net loss attributable to common shareholders was $13.3 million, or $0.07 per diluted share, compared to $16.2 million, or $0.07 per diluted share, respectively. For the nine months ended September 30, 2026 and 2025, net income attributable to common shareholders was $159.4 million, or $0.78 per diluted share, compared to $117.8 million, or $0.54 per diluted share, respectively.

TARRYTOWN, N.Y., Oct. 30, 2026 (GLOBE NEWSWIRE) -- Regeneron Pharmaceuticals, Inc. (Nasdaq: REGN) today announced financial results for the third quarter of 2026 and provided a business update.

HOUSTON and LONDON, Oct. 30, 2026 (GLOBE NEWSWIRE) -- LyondellBasell Industries (NYSE: LYB) (the "company") today announced results for the third quarter 2026. Comparisons with the prior quarter and third quarter 2025 are available in the following table:

Private Placement With Institutional Support

BEIJING, Oct. 30, 2026 (GLOBE NEWSWIRE) -- Newlinks Technology Limited (“Newlinks”), the parent company of NaaS Technology Inc. (Nasdaq: NAAS) (“NaaS” or the “Company”), announced that it signed a strategic cooperation agreement with Tencent Cloud at the 2026 Tencent Global Digital Ecosystem Summit held in Shenzhen on October 29, 2026. Under the agreement, the two parties will collaborate in cloud services, artificial intelligence (AI) and the Energy Internet of Things (Energy IoT), jointly exploring innovative applications of AI technology in the energy sector and advancing the evolution of energy digitalization toward intelligent operations.